Cancer Nanomedicine (Record no. 17637)

MARC details
000 -LEADER
fixed length control field 04522nam a2200121Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220615s9999||||xx |||||||||||||| ||und||
245 #0 - TITLE STATEMENT
Title Cancer Nanomedicine
546 ## - LANGUAGE NOTE
Language note English[eng]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element antibody drug conjugate (ADC)||PD-L1||tumor spheroid disruption||immune modulation||doxorubicin||graphene oxide||adsorption||cathepsin D||cathepsin L||anti-metastatic enzyme cancer therapy||nanoparticles||targeted delivery system||siRNA||osteopontin||mammary carcinoma||mesenchymal stem cells (MSCs)||TAT peptide||PLGA||paclitaxel||nano-engineered MSCs||orthotopic lung tumor model||intracranial glioma||immunotherapy||CPMV||viral nanoparticles||in situ vaccine||albumin nanoparticles||microbubble||ultrasound||theranostics||hepatocellular carcinoma||VX2 tumor||intra-arterial chemotherapy||lung cancer||nanomedicine||clinical status||cancer therapy||breast cancer||cell signaling||active targeting||passive targeting||EPR effect||oncogenes||nanoparticle||drug delivery||ligand||tumor targeting||biodistribution||Mesoporous silica nanoparticle||drug delivery system||target treatment||lanthanide metal||hyaluronic acid||hyaluronidase||drug combination||everolimus||dual-targeting||magnetic nanoparticles||monoclonal antibodies||nanostructured lipid carrier||platelet membrane||biomimicry||plasmonic photothermal therapy||gold nanorods||surgery||bleeding||dogs||cats||stimuli-responsive||DOX||SN38||CSCs||single-walled carbon nanotubes||chirality separation||NASH||drug-gene delivery||near IR hyperspectral imaging||plasmonics||copper||VEGF||glioblastoma||differentiated neuroblastoma||peptidomimetics||real-time quantitative polymerase chain reaction (qPCR)||actin||combinatorial therapy||anticancer and antibacterial activity||temoporfin||drug-in-cyclodextrin-in-liposome||hybrid nanoparticles||multicellular tumor spheroids||cyclodextrins||photodynamic therapy article||yet reasonably common within the subject discipline||antitumor strategy||biomimetic core–shell nanoparticles||NK cell-derived exosomes||folate receptor||albumin nanoparticle||microfluidic||cabazitaxel||polydopamine nanoparticles||size||cytotoxicity||iron affinity||FA-DABA-SMA||self-assembly||oncogenic proteins||intracellular disruption||folic receptor alpha||pancreatic cancer||parvifloron D||albumin||erlotinib||photodynamic therapy||lipid nanoparticles||tumor vectorization||verteporfin||ovarian carcinomatosis||spheroids||integrin||RGD peptide||cancer diagnosis||radiotherapy||hyperthermia therapy||biomimetic||nanocarrier||membrane-wrapped||cancer||targeted delivery||photothermal therapy||imaging||cancer nanomedicine||tumor microenvironment||nano–bio interactions||clinical translation||magnetic nanowires||magnetic hyperthermia||magnetic actuation||magnetic drug targeting||titanate nanotubes||gold nanoparticles||vectorization||colloidal stability||docetaxel||prostate cancer||mangiferin||anti-topoisomerase activity||extracellular vesicles||exosomes||chemico-physical functionalization||loading||translational medicine||nanotechnology: bioengineering||anacardic acid||mitoxantrone||targeted drug delivery||liposomes||melanoma||apoptosis||ascorbic acid||angiogenesis||epithelial-to-mesenchymal transition||hypoxia||immunosuppression||metabolism||nanotherapeutics||tumour microenvironment||DNA origami||liposome||remote loading||acute toxicity||organoids||magnetic silica-coated iron oxide nanochains||photothermal treatment||hyperthermia||collagen||cellular microenvironment||lymphadenectomy||magnetometer||sentinel lymph node dissection||SPION||superparamagnetic iron oxide nanoparticles||Vδ2 T cells||zoledronic acid||polymeric nanoconstruct||anti-tumor immunity||colorectal carcinoma||β-cyclodextrin nanosponges||BALB-neuT mice||brain tumours||glioma||blood brain barrier||polymeric nanoparticles||PEGylation||dioleoylphosphatidylethanolamine||poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer||folate||oxidation-sensitive release||cellular interaction||in vitro anti-cancer activity||triple negative breast cancer||organotin||mesoporous silica nanoparticles||MDA-MB-231||theranostic nanomaterials||nanobiotechnology||molecular imaging||nanosystems||nanomicelles||ovarian cancer||tumour targeting||chemotherapeutics||riboflavin||vitamin B2||nanomedicines||secondary structure||mixed micelle||pH responsive||targeted therapy||anti-cancer||shear stress||flow||in vitro||therapeutics||diagnostics||Immunotherapy
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Hoskins, Clare
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/2846">https://mdpi.com/books/pdfview/book/2846</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E-Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre 15/06/2022   15/06/2022 15/06/2022 E-Books